Cyberdyne

Cyberdyne

Providing development of robots and develops and sells the cyborg-type robot HAL. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
JPY2021202220232024202520262027
Revenues1.9b2.2b3.3b4.4b5.2b6.0b7.2b
% growth5 %15 %53 %32 %20 %14 %20 %
EBITDA514m(17.0m)599m(778m)(135m)471m1.1b
% EBITDA margin27 %(1 %)18 %(18 %)(3 %)8 %16 %
Profit(59.0m)(492m)(298m)(1.5b)(120m)352m892m
% profit margin(3 %)(23 %)(9 %)(34 %)(2 %)6 %12 %
EV / revenue59.8x27.0x13.2x5.9x4.7x4.0x3.3x
EV / EBITDA218.3x-3415.1x72.3x-33.0x-181.2x51.3x20.4x
R&D budget689m713m735m877m---
R&D % of revenue37 %33 %22 %20 %---
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Early VC

N/A

Seed

JPY1.0b

Late VC
N/A

JPY650m

Early VC

JPY750m

Late VC
N/A

JPY217m

Early VC
N/A

JPY2.2b

Early VC

N/A

-
N/A

N/A

IPO
Total FundingAUD57.3m

Recent News about Cyberdyne

Edit
More about Cyberdyneinfo icon
Edit

Cyberdyne Inc. is a pioneering company in the field of robotic and cybernics technology, specializing in medical rehabilitation devices. The company primarily serves healthcare providers, rehabilitation centers, and individual patients who require advanced solutions for conditions such as cerebral infarction, stroke, spinal injury, and fatigue. Operating in the medical technology market, Cyberdyne's core product is the Hybrid Assistive Limb (HAL), a robotic exoskeleton that supports and enhances human movement. The business model revolves around the sale and leasing of HAL units, as well as providing associated services and support. Revenue is generated through direct sales, subscription plans, and service contracts. Cyberdyne's innovative approach combines robotics with biological and neurological sciences to create cutting-edge solutions that significantly improve patient outcomes.

Keywords: robotic exoskeleton, medical rehabilitation, Hybrid Assistive Limb, healthcare technology, cerebral infarction, stroke recovery, spinal injury, fatigue management, advanced technology, cybernics.